Dihexa is a small-molecule angiotensin IV derivative studied for hepatocyte growth factor potentiation and synaptogenesis in preclinical cognitive research models.
Dihexa is an orally stable angiotensin IV-derived research compound developed at Washington State University. It is studied for its capacity to potentiate hepatocyte growth factor (HGF) and its receptor c-Met, a pathway linked to synapse formation, with preclinical work examining synaptogenesis and cognition-related endpoints in animal models.
Research Applications
Handling & Storage
Supplied as a lyophilized powder. Store sealed vials in a cool, dry place away from light; refrigerate after reconstitution and avoid repeated freeze-thaw cycles.
This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Dihexa is a small-molecule angiotensin IV derivative studied for hepatocyte growth factor potentiation and synaptogenesis in preclinical cognitive research models. This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 4PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
Every batch of Dihexa is independently tested for identity and purity, and ships with its own Certificate of Analysis — lot information included, where a researcher can actually find it.
View Testing Documentation →Batch COA provided with every order.
